Aplicación YC de Matrubials

Summer 2021Active

Matrubials pasó por Y Combinator en el batch Summer 2021 como una empresa de Healthcare. Abajo: qué hace la empresa, quién la fundó y su aplicación a YC, reconstruida pregunta por pregunta en el formulario real de YC.

Batch YC: Summer 2021
Industria: HealthcareDrug Discovery and Delivery
Tamaño del equipo: 4
Estado: Active
Lanzado: 2021

Fundadores

Bruce GermanFounder
Carlito LebrillaFounder
David MillsFounder

Lo que hace Matrubials

Matrubials is an anti-infectives company, focused on human milk peptides as therapeutics to address antimicrobial resistance and modern diseases. Currently the global rise in severe bacterial infections and the drying pipeline of effective treatments are burdensome for healthcare and economics. Sculpted by evolution, milk, first food for the newborn, provides an exemplary solution to address the nutritive and protective challenges an infant is faced with. The anti-pathogenic molecules from milk can be developed into therapeutics geared towards all-age diseases. Our first indication is bacterial vaginosis, a bacterial dysbiosis related inflammation that results in recurrent infections, disruption of homeostasis and long-term clinical complications in women of reproductive age, including but not limited to preterm births, fertility issues and increased rates of STDs. Our next inflection point is the evaluation of rapidly acting and selective candidate peptides in pre-clinical host impact and early safety studies, which can aid clinical and portfolio development towards topical applications.

Aplicación YC de Matrubials, reconstruida

Solicitud de Y Combinator

Matrubials, batch Summer 2021. Las preguntas reales del formulario, respondidas con datos públicos.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Matrubials

Describe what your company does in 50 characters or less.

Milk-inspired therapeutics for infectious diseases

What is your company going to make? Please describe your product and what it does or will do.

We are developing antimicrobial peptides derived from human milk to treat bacterial infections. Our lead program targets bacterial vaginosis, aiming to restore microbial balance and prevent recurrent infections and inflammation that affect women's reproductive health. These peptides act selectively to avoid disrupting beneficial bacteria and offer a novel treatment approach against antimicrobial resistance.

Where do you live now, and where would the company be based after YC?

We live and work in Davis, CA. After YC, the company will remain based here to leverage local research connections and our core scientific team.

Explain your decision regarding location.

Davis hosts our founders and is near key research institutions. Staying here maintains continuity in science and development and supports our focused approach on milk-based therapeutics.

21 respuestas más en la aplicación completa

están en la versión completa. Crea una cuenta gratuita para abrirla en YC Insights, junto a cada otro batch de YC.

Ver aplicación completa

Preguntas Frecuentes

¿Es esta la aplicación YC real de Matrubials?

No. Y Combinator mantiene privadas las aplicaciones enviadas. Esta es una reconstrucción: las preguntas reales del formulario de YC, respondidas a partir de los datos públicos de Matrubials (notas de lanzamiento, antecedentes de fundadores, descripción del producto). Muestra cómo una empresa como Matrubials se presentaría a YC, no el texto que enviaron.

¿En qué batch de YC estuvo Matrubials?

Matrubials formó parte del batch Summer 2021 de Y Combinator.

¿Quién fundó Matrubials?

Matrubials fue fundado por Bruce German, Carlito Lebrilla, David Mills.

¿A qué se dedica Matrubials?

Developing milk-inspired therapeutics for infectious diseases

¿Cómo leo la aplicación completa reconstruida?

Crea una cuenta gratuita de Round Funded. La versión completa de 26 respuestas de la aplicación de Matrubials, y de cada otro batch de YC, está en YC Insights.